Intramolecular trans-sialidase as alternative therapeutics against COVID-19
- Funded by British Society for Antimicrobial Chemotherapy (BSAC)
- Total publications:0 publications
Grant number: BSAC-COVID-39
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$31,250Funder
British Society for Antimicrobial Chemotherapy (BSAC)Principal Investigator
Nathalie JugeResearch Location
United KingdomLead Research Institution
Quadram Institute Bioscience, Norwich Research Park, Norwich, EnglandResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
N/ASpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable